| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,181 |
23,903 |
$1.63M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,253 |
8,602 |
$791K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,123 |
4,995 |
$374K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,935 |
4,773 |
$368K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,652 |
3,917 |
$304K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,375 |
3,274 |
$269K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,711 |
3,566 |
$112K |
| 92551 |
|
10,780 |
10,442 |
$90K |
| 90651 |
|
2,244 |
2,174 |
$89K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,324 |
3,077 |
$84K |
| 90670 |
|
2,892 |
2,763 |
$69K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,802 |
1,723 |
$59K |
| 99188 |
|
2,993 |
2,906 |
$52K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,851 |
3,669 |
$51K |
| 90716 |
|
2,023 |
1,966 |
$50K |
| 90698 |
|
2,663 |
2,536 |
$46K |
| 99381 |
|
824 |
618 |
$45K |
| 90680 |
|
2,304 |
2,186 |
$38K |
| 90621 |
|
883 |
854 |
$35K |
| 90707 |
|
1,899 |
1,842 |
$35K |
| 81002 |
|
12,624 |
12,045 |
$35K |
| 90671 |
|
619 |
599 |
$33K |
| 90734 |
|
1,231 |
1,183 |
$32K |
| 90633 |
|
2,356 |
2,278 |
$30K |
| 97802 |
|
14,262 |
13,758 |
$28K |
| 90744 |
|
2,246 |
2,044 |
$25K |
| 90686 |
|
2,293 |
2,246 |
$25K |
| 99173 |
|
10,744 |
10,414 |
$21K |
| 90674 |
|
1,033 |
1,000 |
$20K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,266 |
7,729 |
$19K |
| 90715 |
|
1,144 |
1,105 |
$16K |
| 90656 |
|
1,277 |
1,222 |
$15K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
202 |
195 |
$15K |
| 99383 |
|
187 |
181 |
$15K |
| 0001A |
|
327 |
318 |
$12K |
| 0002A |
|
273 |
262 |
$10K |
| 90696 |
|
607 |
592 |
$10K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
988 |
962 |
$10K |
| 0072A |
|
230 |
229 |
$9K |
| 90619 |
|
139 |
137 |
$9K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
65 |
61 |
$8K |
| 90700 |
|
595 |
566 |
$7K |
| 0071A |
|
178 |
174 |
$7K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
526 |
494 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
77 |
76 |
$6K |
| 90461 |
|
3,072 |
2,916 |
$5K |
| 90655 |
|
426 |
402 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
287 |
263 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
115 |
112 |
$4K |
| 94664 |
|
288 |
262 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
42 |
41 |
$3K |
| 83655 |
|
260 |
255 |
$3K |
| 99384 |
|
33 |
31 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
55 |
53 |
$2K |
| 90648 |
|
251 |
233 |
$2K |
| 90733 |
|
89 |
85 |
$2K |
| 94760 |
|
1,673 |
1,448 |
$2K |
| 99442 |
|
55 |
52 |
$2K |
| 99401 |
|
47 |
43 |
$2K |
| 99000 |
|
596 |
555 |
$1K |
| 99382 |
|
12 |
12 |
$1K |
| 99051 |
|
278 |
254 |
$1K |
| 85018 |
|
426 |
420 |
$951.97 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
90 |
87 |
$893.84 |
| 90710 |
|
17 |
17 |
$601.83 |
| 87807 |
|
54 |
41 |
$541.46 |
| 0003A |
|
14 |
14 |
$280.00 |
| 90713 |
|
14 |
14 |
$239.48 |
| 96380 |
|
17 |
14 |
$193.20 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
26 |
$44.20 |
| 91307 |
|
322 |
292 |
$2.11 |
| 91300 |
|
299 |
250 |
$1.99 |
| 91308 |
|
18 |
15 |
$0.16 |
| 99072 |
|
394 |
382 |
$0.00 |